Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.verified

PLRX

Price:

$15.27

Market Cap:

$921.17M

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an ...[Read more]

Industry

Biotechnology

IPO Date

2020-06-03

Stock Exchange

NASDAQ

Ticker

PLRX

The PE Ratio as of May 2024 (TTM) for Pliant Therapeutics, Inc. (PLRX) is -5.34

According to Pliant Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.34. This represents a change of -11.32% compared to the average of -6.02 of the last 4 quarters.

Pliant Therapeutics, Inc. (PLRX) Historical PE Ratio (quarterly & annually)

How has PLRX PE Ratio performed in the past?

The mean historical PE Ratio of Pliant Therapeutics, Inc. over the last ten years is 670.16. The current -5.34 PE Ratio has changed -179.68% with respect to the historical average. Over the past ten years (40 quarters), PLRX's PE Ratio was at its highest in in the March 2020 quarter at 15.08. The PE Ratio was at its lowest in in the March 2021 quarter at -15.33.

Quarterly (TTM)
Annual

Average

670.16

Median

-9.15

Minimum

-27.02

Maximum

4.09K

Pliant Therapeutics, Inc. (PLRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pliant Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 32.97%

Maximum Annual PE Ratio = 4.09K

Minimum Annual Increase = -35339.81%

Minimum Annual PE Ratio = -27.02

Quarterly (TTM)
Annual
YearPE RatioChange
2023-6.59-1.40%
2022-6.68-75.26%
2021-27.0232.97%
2020-20.32-100.50%
20194.09K-35339.81%

Pliant Therapeutics, Inc. (PLRX) Average PE Ratio

How has PLRX PE Ratio performed in the past?

The current PE Ratio of Pliant Therapeutics, Inc. (PLRX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-13.43

5-year avg

806.52

10-year avg

670.16

Pliant Therapeutics, Inc. (PLRX) PE Ratio vs. Peers

How is PLRX’s PE Ratio compared to its peers?

Pliant Therapeutics, Inc.’s PE Ratio is less than Relay Therapeutics, Inc. (-2.64), greater than Stoke Therapeutics, Inc. (-5.92), less than Black Diamond Therapeutics, Inc. (-3.16), greater than Arvinas, Inc. (-6.60), less than 89bio, Inc. (-5.01), greater than Madrigal Pharmaceuticals, Inc. (-9.91), greater than Arcellx, Inc. (-55.97), greater than Dyne Therapeutics, Inc. (-8.72), greater than Cytokinetics, Incorporated (-11.44), greater than Revolution Medicines, Inc. (-13.41), greater than Syndax Pharmaceuticals, Inc. (-7.19), less than Viridian Therapeutics, Inc. (-3.77), less than Inozyme Pharma, Inc. (-3.68), less than TCR2 Therapeutics Inc. (-0.44), less than Atreca, Inc. (-0.04), less than Passage Bio, Inc. (-0.88),

Build a custom stock screener for Pliant Therapeutics, Inc. (PLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pliant Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pliant Therapeutics, Inc. (PLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pliant Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pliant Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Pliant Therapeutics, Inc. (PLRX)?

What is the highest PE Ratio for Pliant Therapeutics, Inc. (PLRX)?

What is the 3-year average PE Ratio for Pliant Therapeutics, Inc. (PLRX)?

What is the 5-year average PE Ratio for Pliant Therapeutics, Inc. (PLRX)?

How does the current PE Ratio for Pliant Therapeutics, Inc. (PLRX) compare to its historical average?